You Were Only Supposed To Be On PPI's For Eight Weeks. It's Been Years.
Here is something almost nobody tells you when the prescription gets handed over.
Proton pump inhibitors, omeprazole, lansoprazole, esomeprazole, the purple pill, were approved by the FDA for short courses. The labeling is specific: four to eight weeks to heal the tissue, with the option of one additional short course if symptoms come back. The clinical trials that proved these drugs work were not run longer than twelve months. That is the entire evidence base.
You have been on yours for three years. Maybe five. Maybe you genuinely cannot remember the last time you went a week without taking one.
Nobody sat you down and explained that the studies stop at twelve months. Nobody mentioned that the original approval was for two months, not two decades. The refill just kept happening, year after year, because stopping felt impossible and nobody offered you a different plan.
That gap, between what the drug was approved for and how long you have actually been on it, is not an accident. It is the default outcome of a system with no incentive to close it.
Why The Prescription Just Keeps Renewing.
This is not a story about a doctor doing something wrong. Most are simply working inside a system that makes renewal the path of least resistance.
A PPI prescription is fast to renew and slow to question. There is no follow-up mechanism built into most primary care visits that flags "this patient has been on acid suppression for four years, let's reassess why." The drug is generic, inexpensive, and rarely causes an acute, attributable problem in the room, so renewing it costs nothing in the fifteen minutes you get with your doctor. Reassessing the root cause costs time nobody is reimbursed for.
The result is a default setting, not a conspiracy: the path that requires no extra effort from anyone is "keep refilling," and the path that requires effort, asking why you still need it, what else might be going on, what coming off would actually take, almost never gets walked.
You are not imagining that nobody has reassessed this with you in years. You are describing exactly how the incentive structure is built.
Why Stopping Feels Impossible.
If you have ever tried to come off your PPI and felt like your reflux came back twice as bad within days, you were not wrong, and you were not failing.
This has a name in the research: rebound acid hypersecretion. Suppressing stomach acid for an extended period causes the stomach to compensate by producing more acid-stimulating hormone than it did before treatment started. When the drug stops, that compensation does not stop with it. Acid production spikes, often worse than your original symptoms, for days or weeks. Most people interpret that spike as proof they still need the drug. It is more accurately proof that the drug itself created a dependency the original prescription never warned you about.
This is precisely why so many long-term users describe the same trapped feeling: it is not that the PPI is working perfectly and they are choosing to stay on it. It is that stopping has become its own ordeal, and nobody prepared them for that ordeal in advance.
What Years On A PPI Can Actually Cost You.
None of this is meant to alarm you into stopping a medication on your own. It is meant to give you the same picture a fifteen-minute appointment rarely has time to provide.
Long-term PPI use, beyond the window the drugs were actually studied for, has been associated in the research with reduced absorption of vitamin B12 and magnesium, increased fracture risk with extended use, and a documented increase in certain infections tied to lower stomach acid's natural antimicrobial role. None of this means the drug was a mistake for you. It means a medication built for an eight-week job was, in your case, asked to do a decade-long one, largely because nobody offered a structured way off.
If you are on a PPI, the right next step is a conversation with your prescribing doctor about whether continued use still serves an active purpose, not stopping cold on your own. What you can do independently is address the part of this your PPI was never designed to touch in the first place: the tissue damage already done, and the gut imbalance that keeps letting acid rise.
A PPI's entire job is reducing how much acid your stomach makes. That is the whole mechanism, beginning to end. It was never built to repair tissue pepsin has already damaged, and it was never built to fix the gut imbalance letting acid rise in the first place. You could be on the strongest dose available and that layer would still be sitting there, completely untouched. That is the specific gap Infuse was formulated to close.
See What Actually Addresses The Tissue Damage →
- Targets the gut imbalance and tissue damage a PPI was never designed to address
- Slippery elm bark physically coats the throat lining pepsin is already attached to
- Not a replacement for your prescription, a different layer of the problem entirely
- 90-Day money-back guarantee. No questions asked.
The Gut Fire. And The Tissue Your Prescription Never Touched.
A PPI addresses exactly one variable: how much acid your stomach makes. It was never built to address the two failures actually driving chronic LPR symptoms, the reason so many long-term users still have them.
The gut fire. Microbiome imbalance weakening the lower esophageal sphincter, letting acid rise more easily regardless of how suppressed your stomach acid is.
The throat tissue. Pepsin already bound to the lining, sitting dormant, reactivating with whatever acid the PPI does not fully eliminate.
The Kombucha Live Cultures in Infuse work on the gut imbalance directly, supporting the sphincter function a PPI was never designed to repair.
The Slippery Elm Bark physically coats the already-damaged throat tissue, giving it a chance to heal while the underlying imbalance is addressed.
This does not replace a conversation with your doctor about your prescription. It addresses the layer of the problem no prescription, no matter how long you have been on it, was ever built to reach.
Two Paths. One Decision.
Further Reading
General background research on PPI use and reflux-related tissue effects, provided for context. These sources are not studies of Infuse and do not test or evaluate this product.
Reimer C, Sondergaard B, Hilsted L, Bytzer P. "Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy." Gastroenterology, 2009. FDA Prescribing Information, Prilosec (omeprazole) label, accessdata.fda.gov. Koufman JA. "The otolaryngologic manifestations of gastroesophageal reflux disease." Laryngoscope, 1991. Johnston N et al. "Pepsin in nonacidic reflux can damage hypopharyngeal epithelial cells." Annals of Otology, Rhinology and Laryngology, 2003.